-
Je něco špatně v tomto záznamu ?
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C. Buske, M. Dreyling, A. Alvarez-Larrán, J. Apperley, L. Arcaini, C. Besson, L. Bullinger, P. Corradini, M. Giovanni Della Porta, M. Dimopoulos, S. D'Sa, HT. Eich, R. Foà, P. Ghia, MG. da Silva, J. Gribben, R. Hajek, C. Harrison, M. Heuser, B....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
NLK
PubMed Central
od 2016
Europe PubMed Central
od 2016
Open Access Digital Library
od 2016-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2016
- MeSH
- COVID-19 * MeSH
- hematologické nádory * epidemiologie terapie MeSH
- konsensus MeSH
- lidé MeSH
- pandemie MeSH
- testování na COVID-19 MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. METHODS: This consensus manuscript aims at discussing clinical evidence and providing expert advice on statements related to the management of HMs in the COVID-19 pandemic. For this purpose, an international consortium was established including a steering committee, which prepared six working packages addressing significant clinical questions from the COVID-19 diagnosis, treatment, and mitigation strategies to specific HMs management in the pandemic. During a virtual consensus meeting, including global experts and lead by the European Society for Medical Oncology and the European Hematology Association, statements were discussed and voted upon. When a consensus could not be reached, the panel revised statements to develop consensual clinical guidance. RESULTS AND CONCLUSION: The expert panel agreed on 33 statements, reflecting a consensus, which will guide clinical decision making for patients with hematological neoplasms during the COVID-19 pandemic.
Barts Cancer Institute Queen Mary University of London London UK
Cancer Center IRCCS Humanitas Research Hospital Rozzano Milan Italy
Centre for Haematology Imperial College London Hammersmith Hospital London UK
CIBERONC IS Carlos 3 Madrid Spain
Clínica Universidad de Navarra CIBERONC Pamplona Spain
Department of Biomedical Sciences Humanitas University Pieve Emanuele Milan Italy
Department of Hematology and Medical Oncology University Hospital Jena Jena Germany
Department of Hematology Medical University of Lodz Lodz Poland
Department of Hematology Oncology and Tumorimmunology Campus Virchow Klinikum Berlin Germany
Department Of Hematology Portuguese Institute of Oncology Lisbon Portugal
Department of Hematooncology Faculty of Medicine University of Ostrava Ostrava Czech Republic
Department of Medicine 1 Division of Oncology Medical University of Vienna Vienna Austria
Department of Medicine 3 at LMU Hospital Munich Germany
Department of Medicine and Surgery University of Insubria Varese Italy
Department of Molecular Medicine University of Pavia Pavia Italy
Department of Pathophysiology and Transplantation University of Milan Milan Italy
Department of Radiation Oncology University of Muenster Münster Germany
Department of Stem Cell Transplantation University Hospital Hamburg Eppendorf Hamburg Germany
Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy
Erasmus MC Cancer Institute Department of Haematology Rotterdam The Netherlands
Hematology Department Hospital Clínic IDIBAPS Barcelona Spain
Hematology Department Hospital Univesitario y Politecnico La Fe Valencia
Hematology Department of Translational and Precision Medicine Sapienza University Rome Italy
Hematology Department University Hospital Hotel Dieu Nantes France
Hematology Division Basel University Hospital Basel Switzerland
MDS Unit Hematology DMSC AOUC University of Florence Florence Italy
Munich Clinic Schwabing Academic Teaching Hospital Ludwig Maximilian University Munich Germany
Scientific and Medical Division European Society for Medical Oncology Lugano Switzerland
Service d'Hématologie Oncologie Centre Hospitalier de Versailles Le Chesnay France
Université de Paris APHP Hôpital Saint Louis Centre d'Investigations Cliniques Paris France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018948
- 003
- CZ-PrNML
- 005
- 20240516083111.0
- 007
- ta
- 008
- 220720s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.esmoop.2022.100403 $2 doi
- 035 __
- $a (PubMed)35272130
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Buske, C $u Institute of Experimental Cancer Research, Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany. Electronic address: christian.buske@uni-ulm.de
- 245 10
- $a Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus / $c C. Buske, M. Dreyling, A. Alvarez-Larrán, J. Apperley, L. Arcaini, C. Besson, L. Bullinger, P. Corradini, M. Giovanni Della Porta, M. Dimopoulos, S. D'Sa, HT. Eich, R. Foà, P. Ghia, MG. da Silva, J. Gribben, R. Hajek, C. Harrison, M. Heuser, B. Kiesewetter, JJ. Kiladjian, N. Kröger, P. Moreau, JR. Passweg, F. Peyvandi, D. Rea, JM. Ribera, T. Robak, JF. San-Miguel, V. Santini, G. Sanz, P. Sonneveld, M. von Lilienfeld-Toal, C. Wendtner, G. Pentheroudakis, F. Passamonti
- 520 9_
- $a BACKGROUND: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. METHODS: This consensus manuscript aims at discussing clinical evidence and providing expert advice on statements related to the management of HMs in the COVID-19 pandemic. For this purpose, an international consortium was established including a steering committee, which prepared six working packages addressing significant clinical questions from the COVID-19 diagnosis, treatment, and mitigation strategies to specific HMs management in the pandemic. During a virtual consensus meeting, including global experts and lead by the European Society for Medical Oncology and the European Hematology Association, statements were discussed and voted upon. When a consensus could not be reached, the panel revised statements to develop consensual clinical guidance. RESULTS AND CONCLUSION: The expert panel agreed on 33 statements, reflecting a consensus, which will guide clinical decision making for patients with hematological neoplasms during the COVID-19 pandemic.
- 650 12
- $a COVID-19 $7 D000086382
- 650 _2
- $a testování na COVID-19 $7 D000086742
- 650 _2
- $a konsensus $7 D032921
- 650 12
- $a hematologické nádory $x epidemiologie $x terapie $7 D019337
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a pandemie $7 D058873
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dreyling, M $u Department of Medicine III at LMU Hospital, Munich, Germany
- 700 1_
- $a Alvarez-Larrán, A $u Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain
- 700 1_
- $a Apperley, J $u Centre for Haematology, Imperial College London, Hammersmith Hospital, London, UK
- 700 1_
- $a Arcaini, L $u Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Pavia, Italy
- 700 1_
- $a Besson, C $u Service d'Hématologie Oncologie, Centre Hospitalier de Versailles, Le Chesnay, France; UVSQ, Inserm, CESP, Villejuif, France
- 700 1_
- $a Bullinger, L $u Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- 700 1_
- $a Corradini, P $u Hematology Division, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
- 700 1_
- $a Giovanni Della Porta, M $u Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
- 700 1_
- $a Dimopoulos, M $u Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a D'Sa, S $u UCLH Centre for Waldenström and Neurohaematology, University College London Hospitals NHS Foundation Trust, London, UK
- 700 1_
- $a Eich, H T $u Department of Radiation Oncology, University of Muenster, Münster, Germany
- 700 1_
- $a Foa, Robin $u Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy $7 xx0317383
- 700 1_
- $a Ghia, P $u Strategic Research Program on Chronic Lymphocytic Leukemia and Laboratory of B Cell Neoplasia, Division of Molecular Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy
- 700 1_
- $a da Silva, M G $u Department Of Hematology, Portuguese Institute of Oncology, Lisbon, Portugal
- 700 1_
- $a Gribben, J $u Barts Cancer Institute, Queen Mary University of London, London, UK
- 700 1_
- $a Hajek, R $u Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Harrison, C $u Clinical Director - Haematology, Haemostasis, Palliative Care, Cellular Pathology, Guy's and St Thomas' NHS Foundation Trust, London, UK
- 700 1_
- $a Heuser, M $u Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany
- 700 1_
- $a Kiesewetter, B $u Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Kiladjian, J J $u Université de Paris, APHP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, Paris, France
- 700 1_
- $a Kröger, N $u Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Moreau, P $u Hematology Department, University Hospital Hotel-Dieu, Nantes, France
- 700 1_
- $a Passweg, J R $u Hematology Division, Basel University Hospital, Basel, Switzerland
- 700 1_
- $a Peyvandi, F $u Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
- 700 1_
- $a Rea, D $u University Medical Department of Hematology and Immunology, France Intergroupe des Leucémies Myéloïdes Chroniques (Fi-LMC), Hôpital Saint-Louis, Paris, France
- 700 1_
- $a Ribera, J-M $u Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain
- 700 1_
- $a Robak, T $u Department of Hematology, Medical University of Lodz, Lodz, Poland
- 700 1_
- $a San-Miguel, J F $u Clínica Universidad de Navarra (CUN), Centro de Investigación Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBERONC, Pamplona, Spain
- 700 1_
- $a Santini, V $u MDS Unit, Hematology, DMSC, AOUC, University of Florence, Florence, Italy
- 700 1_
- $a Sanz, G $u Hematology Department, Hospital Univesitario y Politecnico La Fe, Valencia; CIBERONC, IS Carlos III, Madrid, Spain
- 700 1_
- $a Sonneveld, P $u Erasmus MC Cancer Institute, Department of Haematology, Rotterdam, The Netherlands
- 700 1_
- $a von Lilienfeld-Toal, M $u Department of Hematology and Medical Oncology, University Hospital Jena, Jena, Germany; Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany
- 700 1_
- $a Wendtner, C $u Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilian University, Munich, Germany
- 700 1_
- $a Pentheroudakis, G $u Scientific and Medical Division, European Society for Medical Oncology, Lugano, Switzerland
- 700 1_
- $a Passamonti, F $u Department of Medicine and Surgery, University of Insubria, Varese, Italy. Electronic address: Francesco.Passamonti@asst-settelaghi.it
- 773 0_
- $w MED00196632 $t ESMO open $x 2059-7029 $g Roč. 7, č. 2 (2022), s. 100403
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35272130 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20240516083105 $b ABA008
- 999 __
- $a ok $b bmc $g 1822507 $s 1170191
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 7 $c 2 $d 100403 $e 20220128 $i 2059-7029 $m ESMO open $n ESMO Open $x MED00196632
- LZP __
- $a Pubmed-20220720
